Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Squamous Cell | 6 | 2020 | 1107 | 0.800 |
Why?
|
| Head and Neck Neoplasms | 5 | 2020 | 1091 | 0.720 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 218 | 0.580 |
Why?
|
| Cisplatin | 1 | 2020 | 578 | 0.530 |
Why?
|
| Chemoradiotherapy | 2 | 2020 | 337 | 0.530 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 131 | 0.380 |
Why?
|
| Skin Ulcer | 1 | 2012 | 28 | 0.370 |
Why?
|
| Hodgkin Disease | 1 | 2012 | 144 | 0.350 |
Why?
|
| Adenosine Deaminase | 1 | 2011 | 31 | 0.320 |
Why?
|
| Uric Acid | 1 | 2011 | 137 | 0.310 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 219 | 0.300 |
Why?
|
| Skin | 1 | 2012 | 592 | 0.290 |
Why?
|
| Lymph Nodes | 1 | 2012 | 563 | 0.280 |
Why?
|
| Mouth Neoplasms | 3 | 2020 | 223 | 0.280 |
Why?
|
| Naegleria fowleri | 1 | 2008 | 1 | 0.280 |
Why?
|
| Central Nervous System Protozoal Infections | 1 | 2008 | 1 | 0.280 |
Why?
|
| Amebiasis | 1 | 2008 | 3 | 0.280 |
Why?
|
| Mouth Mucosa | 2 | 2015 | 72 | 0.270 |
Why?
|
| Registries | 1 | 2014 | 1133 | 0.270 |
Why?
|
| India | 6 | 2020 | 148 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2013 | 2666 | 0.210 |
Why?
|
| Leiomyosarcoma | 2 | 2015 | 48 | 0.200 |
Why?
|
| Pharyngeal Diseases | 1 | 2003 | 10 | 0.200 |
Why?
|
| Granuloma, Giant Cell | 1 | 2003 | 5 | 0.200 |
Why?
|
| Bone Diseases | 1 | 2003 | 51 | 0.190 |
Why?
|
| Sigmoid Neoplasms | 1 | 2002 | 9 | 0.190 |
Why?
|
| Carcinoma | 2 | 2023 | 442 | 0.180 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2002 | 53 | 0.180 |
Why?
|
| Humans | 36 | 2023 | 98799 | 0.180 |
Why?
|
| Teratoma | 4 | 2010 | 57 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2012 | 2680 | 0.170 |
Why?
|
| Adult | 16 | 2020 | 29698 | 0.170 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 2087 | 0.170 |
Why?
|
| Penile Neoplasms | 2 | 2015 | 20 | 0.170 |
Why?
|
| Sclerotherapy | 1 | 2001 | 20 | 0.170 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 2001 | 2 | 0.170 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2001 | 40 | 0.170 |
Why?
|
| Esophageal Diseases | 1 | 2001 | 26 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 201 | 0.160 |
Why?
|
| Male | 22 | 2023 | 47475 | 0.160 |
Why?
|
| Female | 22 | 2023 | 51997 | 0.160 |
Why?
|
| Aged | 13 | 2020 | 21986 | 0.160 |
Why?
|
| Combined Modality Therapy | 5 | 2020 | 1754 | 0.160 |
Why?
|
| Esophagus | 1 | 2001 | 113 | 0.160 |
Why?
|
| Pancreatectomy | 1 | 2001 | 222 | 0.150 |
Why?
|
| Neoplasms | 2 | 2014 | 3382 | 0.150 |
Why?
|
| Middle Aged | 16 | 2023 | 29642 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2001 | 217 | 0.150 |
Why?
|
| Placenta | 1 | 2001 | 202 | 0.140 |
Why?
|
| Neoadjuvant Therapy | 1 | 2022 | 477 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 608 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2001 | 251 | 0.140 |
Why?
|
| Ethanol | 1 | 2001 | 287 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 362 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2023 | 4837 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 1196 | 0.130 |
Why?
|
| Patient Safety | 1 | 2020 | 237 | 0.130 |
Why?
|
| Survival Rate | 3 | 2020 | 2057 | 0.130 |
Why?
|
| Follow-Up Studies | 5 | 2014 | 4049 | 0.120 |
Why?
|
| Young Adult | 4 | 2014 | 7598 | 0.120 |
Why?
|
| Penis | 2 | 2015 | 65 | 0.120 |
Why?
|
| Hoarseness | 1 | 2015 | 12 | 0.120 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 675 | 0.120 |
Why?
|
| Vocal Cords | 1 | 2015 | 27 | 0.110 |
Why?
|
| Laryngeal Neoplasms | 1 | 2015 | 89 | 0.110 |
Why?
|
| Doxorubicin | 2 | 2013 | 285 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2001 | 782 | 0.110 |
Why?
|
| Child | 7 | 2014 | 7771 | 0.110 |
Why?
|
| Prognosis | 4 | 2023 | 4139 | 0.100 |
Why?
|
| Positron-Emission Tomography | 2 | 2013 | 354 | 0.100 |
Why?
|
| Eosinophilic Granuloma | 1 | 2013 | 9 | 0.100 |
Why?
|
| Family Characteristics | 1 | 2014 | 52 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1177 | 0.100 |
Why?
|
| Colitis, Ulcerative | 1 | 2001 | 844 | 0.100 |
Why?
|
| Demography | 1 | 2014 | 193 | 0.100 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 3 | 2005 | 215 | 0.100 |
Why?
|
| Adolescent | 7 | 2014 | 10168 | 0.100 |
Why?
|
| Vagus Nerve Diseases | 1 | 2012 | 1 | 0.090 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2012 | 12 | 0.090 |
Why?
|
| Vinblastine | 1 | 2012 | 84 | 0.090 |
Why?
|
| Bleomycin | 1 | 2012 | 102 | 0.090 |
Why?
|
| Neurilemmoma | 1 | 2012 | 39 | 0.090 |
Why?
|
| Mouth Diseases | 1 | 2012 | 14 | 0.090 |
Why?
|
| Dacarbazine | 1 | 2012 | 104 | 0.090 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 57 | 0.090 |
Why?
|
| Plants, Medicinal | 1 | 2011 | 39 | 0.080 |
Why?
|
| Melanoma | 1 | 2015 | 523 | 0.080 |
Why?
|
| Ondansetron | 1 | 2010 | 8 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2020 | 9806 | 0.080 |
Why?
|
| Mycoses | 1 | 2011 | 46 | 0.080 |
Why?
|
| Quinuclidines | 1 | 2010 | 11 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2010 | 24 | 0.080 |
Why?
|
| Antiemetics | 1 | 2010 | 28 | 0.080 |
Why?
|
| Isoquinolines | 1 | 2010 | 58 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 2386 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 87 | 0.080 |
Why?
|
| Nausea | 1 | 2010 | 95 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 2474 | 0.080 |
Why?
|
| Drug Therapy, Combination | 2 | 2010 | 766 | 0.080 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2010 | 42 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2011 | 184 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2013 | 326 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2011 | 252 | 0.070 |
Why?
|
| Biopsy | 1 | 2012 | 1226 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2010 | 318 | 0.070 |
Why?
|
| Ceftazidime | 1 | 2008 | 8 | 0.070 |
Why?
|
| Amphotericin B | 1 | 2008 | 33 | 0.070 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 26 | 0.070 |
Why?
|
| Rifampin | 1 | 2008 | 23 | 0.070 |
Why?
|
| Treatment Refusal | 1 | 2008 | 69 | 0.070 |
Why?
|
| Empyema | 1 | 2007 | 9 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2008 | 295 | 0.060 |
Why?
|
| Chin | 1 | 2007 | 8 | 0.060 |
Why?
|
| Cleft Lip | 1 | 2007 | 20 | 0.060 |
Why?
|
| Abscess | 1 | 2007 | 94 | 0.060 |
Why?
|
| Neutrophils | 2 | 2023 | 346 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 7461 | 0.060 |
Why?
|
| Radiotherapy Dosage | 4 | 2012 | 478 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 1990 | 845 | 0.050 |
Why?
|
| Radiation Injuries | 1 | 2005 | 160 | 0.050 |
Why?
|
| Sex Distribution | 2 | 2001 | 176 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 30 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2001 | 2604 | 0.050 |
Why?
|
| Skull Base | 1 | 2003 | 57 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 3058 | 0.040 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 157 | 0.040 |
Why?
|
| Radiation Dosage | 2 | 2000 | 233 | 0.040 |
Why?
|
| Laparotomy | 1 | 2001 | 65 | 0.040 |
Why?
|
| Sclerosing Solutions | 1 | 2001 | 8 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 225 | 0.040 |
Why?
|
| Tissue Extracts | 1 | 2001 | 24 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2001 | 83 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2003 | 356 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2023 | 461 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2001 | 91 | 0.040 |
Why?
|
| Age Distribution | 1 | 2001 | 211 | 0.040 |
Why?
|
| Tobacco Use | 1 | 2020 | 36 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2009 | 1120 | 0.040 |
Why?
|
| Health Surveys | 1 | 2001 | 254 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 3303 | 0.040 |
Why?
|
| Incidence | 2 | 2001 | 1798 | 0.040 |
Why?
|
| Patient Participation | 1 | 2001 | 251 | 0.030 |
Why?
|
| Dengue | 1 | 1998 | 53 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 1998 | 149 | 0.030 |
Why?
|
| Tongue Neoplasms | 1 | 1997 | 51 | 0.030 |
Why?
|
| Glottis | 1 | 2015 | 13 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1409 | 0.030 |
Why?
|
| Sphenoid Bone | 1 | 1995 | 8 | 0.030 |
Why?
|
| Larynx | 1 | 2015 | 36 | 0.030 |
Why?
|
| Ependymoma | 1 | 1995 | 30 | 0.030 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1995 | 100 | 0.030 |
Why?
|
| Meningioma | 1 | 1995 | 70 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 1995 | 79 | 0.030 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1995 | 78 | 0.030 |
Why?
|
| Gingiva | 1 | 2013 | 7 | 0.030 |
Why?
|
| Radiography, Panoramic | 1 | 2013 | 7 | 0.030 |
Why?
|
| Prednisolone | 1 | 2013 | 38 | 0.030 |
Why?
|
| Vincristine | 1 | 2013 | 102 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2023 | 11104 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2013 | 285 | 0.020 |
Why?
|
| Proteus Infections | 1 | 2012 | 1 | 0.020 |
Why?
|
| Candidiasis, Oral | 1 | 2012 | 4 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2012 | 16 | 0.020 |
Why?
|
| Fungemia | 1 | 2012 | 15 | 0.020 |
Why?
|
| Aspergillosis | 1 | 2012 | 39 | 0.020 |
Why?
|
| Klebsiella Infections | 1 | 2012 | 35 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 2012 | 38 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2012 | 215 | 0.020 |
Why?
|
| Pseudomonas Infections | 1 | 2012 | 95 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 1846 | 0.020 |
Why?
|
| Bacteremia | 1 | 2012 | 110 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 151 | 0.020 |
Why?
|
| Fungi | 1 | 2011 | 70 | 0.020 |
Why?
|
| Radiation Protection | 1 | 1990 | 28 | 0.020 |
Why?
|
| Vomiting | 1 | 2010 | 109 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 638 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 1274 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2010 | 48 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 394 | 0.020 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 63 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1571 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 288 | 0.020 |
Why?
|
| Nigeria | 1 | 2010 | 174 | 0.020 |
Why?
|
| Infant | 2 | 2010 | 3368 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 864 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2010 | 4053 | 0.020 |
Why?
|
| Animals | 1 | 2008 | 29045 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2007 | 2556 | 0.020 |
Why?
|
| Rectum | 1 | 2009 | 152 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2010 | 1786 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 547 | 0.020 |
Why?
|
| Palliative Care | 1 | 2009 | 291 | 0.010 |
Why?
|
| Fluoroscopy | 1 | 2005 | 139 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 3242 | 0.010 |
Why?
|
| Colon | 1 | 2009 | 566 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1985 | 64 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2007 | 722 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2007 | 205 | 0.010 |
Why?
|
| Testicular Neoplasms | 1 | 1985 | 126 | 0.010 |
Why?
|
| Mammography | 1 | 2007 | 505 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1995 | 3622 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 1037 | 0.010 |
Why?
|
| Platelet Factor 4 | 1 | 2003 | 10 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 54 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2003 | 55 | 0.010 |
Why?
|
| Lymphokines | 1 | 2003 | 74 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 57 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 374 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 197 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 305 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 5586 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 402 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 6295 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2003 | 281 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2005 | 1152 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2000 | 193 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2003 | 978 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 369 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2000 | 325 | 0.010 |
Why?
|
| Climate | 1 | 1998 | 63 | 0.010 |
Why?
|
| Mastectomy | 1 | 2000 | 277 | 0.010 |
Why?
|
| Parotid Gland | 1 | 1997 | 29 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 244 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1998 | 342 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1995 | 244 | 0.010 |
Why?
|
| Dysgerminoma | 1 | 1985 | 7 | 0.000 |
Why?
|